Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. | 300,000 | reported | 16 Mar 2022 | tx 1+300,000 |
| LB PHARMACEUTICALS INC | 175,706 | reported | 10 Sept 2025 | tx 5+1,155,391−183,563 |
| Orexigen Therapeutics, Inc. | 153,050 | reported | 03 Feb 2015 | tx 43+2,633,890−3,211,720 |
| Atara Biotherapeutics, Inc. | 69,494 | reported | 09 Feb 2018 | tx 14+333,357−28,863 |
| SANGAMO THERAPEUTICS, INC | 19,250 | reported | 25 Feb 2019 | tx 3+334,750 |
| Terns Pharmaceuticals, Inc. | 0 | reported | 05 May 2026 | tx 6+110,697−110,697 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 45,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 64,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 1,697 | — | deriv |
| 01 Feb 2026 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 1,697 | 0.00 USD | deriv |
| 10 Sept 2025 | GRANT_AWARD | LB PHARMACEUTICALS INC | 175,706 | — | deriv |
| 10 Sept 2025 | GRANT_AWARD | LB PHARMACEUTICALS INC | 7,857 | — | deriv |
| 10 Sept 2025 | GRANT_AWARD | LB PHARMACEUTICALS INC | 971,828 | 0.00 USD | deriv |
| 10 Sept 2025 | OTHER | LB PHARMACEUTICALS INC | 7,857 | — | deriv |
| 10 Sept 2025 | OTHER | LB PHARMACEUTICALS INC | 175,706 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 45,000 | 0.00 USD | deriv |
| 18 Nov 2024 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 64,000 | 0.00 USD | deriv |
| 16 Mar 2022 | GRANT_AWARD | Lyell Immunopharma, Inc. | 300,000 | 0.00 USD | deriv |
| 25 Feb 2019 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 19,250 | 0.00 USD | |
| 25 Feb 2019 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 115,500 | 0.00 USD | deriv |
| 28 Feb 2018 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 200,000 | 0.00 USD | deriv |
| 09 Feb 2018 | SALE | Atara Biotherapeutics, Inc. | 600 | 38.63 USD | |
| 09 Feb 2018 | SALE | Atara Biotherapeutics, Inc. | 733 | 39.66 USD | |
| 09 Feb 2018 | SALE | Atara Biotherapeutics, Inc. | 600 | 40.62 USD | |
| 09 Feb 2018 | SALE | Atara Biotherapeutics, Inc. | 1,562 | 41.69 USD | |
| 09 Feb 2018 | SALE | Atara Biotherapeutics, Inc. | 4,596 | 36.63 USD | |
| 09 Feb 2018 | SALE | Atara Biotherapeutics, Inc. | 4,123 | 37.38 USD | |
| 06 Feb 2018 | TAX_WITHHOLDING | Atara Biotherapeutics, Inc. | 4,434 | 35.80 USD | |
| 09 Feb 2017 | SALE | Atara Biotherapeutics, Inc. | 633 | 16.16 USD | |
| 09 Feb 2017 | SALE | Atara Biotherapeutics, Inc. | 11,582 | 15.70 USD | |
| 06 Feb 2017 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 49,500 | 0.00 USD |